Establishment Labs Holdings (FRA:3E0) Days Sales Outstanding : 114.10 (As of Jun. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Establishment Labs Holdings Days Sales Outstanding?

Establishment Labs Holdings's average Accounts Receivable for the three months ended in Jun. 2024 was €51.2 Mil. Establishment Labs Holdings's Revenue for the three months ended in Jun. 2024 was €41.0 Mil. Hence, Establishment Labs Holdings's Days Sales Outstanding for the three months ended in Jun. 2024 was 114.10.

The historical rank and industry rank for Establishment Labs Holdings's Days Sales Outstanding or its related term are showing as below:

FRA:3E0' s Days Sales Outstanding Range Over the Past 10 Years
Min: 62.76 Med: 90.64 Max: 127.25
Current: 127.25

During the past 8 years, Establishment Labs Holdings's highest Days Sales Outstanding was 127.25. The lowest was 62.76. And the median was 90.64.

FRA:3E0's Days Sales Outstanding is ranked worse than
86.69% of 819 companies
in the Medical Devices & Instruments industry
Industry Median: 65.05 vs FRA:3E0: 127.25

Establishment Labs Holdings's Days Sales Outstanding increased from Jun. 2023 (87.31) to Jun. 2024 (114.10).

Warning Sign:

If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.

Establishment Labs Holdings Days Sales Outstanding Historical Data

The historical data trend for Establishment Labs Holdings's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Establishment Labs Holdings Days Sales Outstanding Chart

Establishment Labs Holdings Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

81.51

94.95

60.80

65.84

92.14

Establishment Labs Holdings Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Days Sales Outstanding	Get a 7-Day Free Trial															87.31	124.79	148.62	119.81	114.10

Competitive Comparison of Establishment Labs Holdings's Days Sales Outstanding

For the Medical Devices subindustry, Establishment Labs Holdings's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Establishment Labs Holdings's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Establishment Labs Holdings's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Establishment Labs Holdings's Days Sales Outstanding falls into.

Establishment Labs Holdings Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Establishment Labs Holdings's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (33.439	+	43.024)	/	2 )	/	151.443	*	365
=	38.2315					/	151.443	*	365
=	92.14

Establishment Labs Holdings's Days Sales Outstanding for the quarter that ended in Jun. 2024 is calculated as:

	Days Sales Outstanding (Q: Jun. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2024 )	+	Accounts Receivable (A: Jun. 2024 ))	/	count )	/	Revenue (A: Jun. 2024 )	*	Days in Period
=	( (46.771	+	55.723)	/	2 )	/	40.985	*	365 / 4
=	51.247					/	40.985	*	365 / 4
=	114.10

Establishment Labs Holdings (FRA:3E0) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Establishment Labs Holdings Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Establishment Labs Holdings's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Establishment Labs Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Establishment Labs Holdings Inc (FRA:3E0) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

ESTA:USA

Address

Coyol Free Zone, Building B15 and 25, Alajuela, CRI

Website

https://establishmentlabs.com

Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in designing, manufacturing, and marketing silicone-filled breast and body shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.

Establishment Labs Holdings Headlines

No Headlines